Calcium supplements in patients with prostate cancer.
Molokwu
Chidi N
CN
D000726:Androgen Antagonists / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000009:adverse effects*; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors
D000726:Androgen Antagonists; D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates